NIH-funded research R01 grant

Microfluidic prep to capture ultrafast molecular changes in biology

Official title: Microfluidic Preparation of Specimens to Enable Submillisecond Time-Resolved Cryo-EM

Funded at Columbia Univ New York Morningside · NIH-11396405 · Data updated 2026-11-12

A new microfluidic system will quickly prepare samples for time-resolved cryo-EM to capture very fast molecular events related to human biology.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia Univ New York Morningside
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 22, 2023
Project endAugust 31, 2027
Funding year2026
Award (this year)$421,247
NIH project number5R01GM144620-04
Project IDNIH-11396405 on NIH RePORTER

Who could benefit from this research

Could help

Patients with diseases involving fast biomolecular processes such as calcium signaling and ion channel function may ultimately benefit from insights gained by this research.

Less likely to help

Healthy individuals or non-molecularly focused diseases may not directly benefit from these findings.

What this research studies

This project develops a microfluidic cryo-EM prep platform called HURRI to enable reaction times below 20 milliseconds. By delivering precise, rapid sample handling and vitrification, it aims to image short-lived intermediate states of biomolecules that are linked to human disease processes. The approach builds on time-resolved cryo-EM to study reactions at millisecond timescales, addressing a major gap in current preparation methods. If successful, it could reveal transient states of ion channels and receptors important for conditions affecting calcium signaling and cell function. The work combines engineering, microscopy, and biophysics to translate fast molecular events into visual insights for disease mechanisms.

Why it matters

Potential benefit: If successful, patients could benefit from deeper understanding of rapid molecular processes underlying certain diseases, potentially guiding new therapies.

How similar studies have gone: Prior TRCEM work has shown promise at 20–600 ms; this project aims to push to sub-20 ms with a novel microfluidic approach.

Where this research is happening

  • Columbia Univ New York Morningside
    New York, United States
    Active

Researchers

  • Principal investigator: Lin, Qiao — Columbia Univ New York Morningside
  • Study coordinator: Lin, Qiao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.